CTRI/2017/10/010079尚未招募未知
An Open Label Pilot Randomized Controlled Study to Assess the Efficacy of Fecal Microbiota Transplantation (FMT) in Chronic Hepatitis B patients. - FMT-HBV
Dr Shalimar0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.HBsAg positive and HBeAg positive at the time of screening.
- •2.ALT levels â?? normal or any level greater than upper normal limit (ULN)
- •3.DNA- any
- •4.Treated with nucleoside/nucleotide analogues for atleast a year.
- •5.Willing and able to comply with the FMT regimen and all other study requirements.
- •6.The patient or guardian is willing and able to provide written informed consent to participate in the study.
排除标准
- •1.Pregnant or breastfeeding. Women of child bearing potential will be screened with beta human chorionic gonadotropin (ï?¢-HCG).
- •2.Co-infection with hepatitis C virus (HCV) and Human Immunodeficiency Virus I and II (HIV).
- •3.Medical conditions that require prolonged or frequent use of systemic acyclovir or famciclovir (e.g., for recurrent herpes virus infections, etc). Prolonged use means episodic treatment with these agents for periods exceeding 10 days every 3 months, or chronic suppressive therapy.
- •4.History of acute decompensation defined as presence of jaundice, ascites, variceal bleeding, hepatic encephalopathy, or spontaneous bacterial peritonitis.
- •5.Patients with hepatocellular carcinoma (HCC).
- •6.Liver disease due to other etiologies.
- •7.Patient with daily alcohol consumption of more than 30 gm of ethanol or abusing illicit drugs.
- •8.Frequent or prolonged use of systemic corticosteroids (e.g., severe asthma, severe arthritis or autoimmune conditions, organ transplantation, adrenal insufficiency, etc).
- •9.Medical conditions requiring the use of potentially hepatotoxic drugs (e.g. dapsone, erythromycin, fluconazole, ketoconazole, rifampin, anti-tuberculosis regimens, others) or nephrotoxic drugs (e.g., frequent NSAIDs, aminoglycosides, amphotericin B, foscarnet).
- •10.Patients on warfarin or other anticoagulants during 30 days prior to screening or if expected during the present study.
- •11.Other concurrent medical conditions likely to preclude compliance with the schedule of evaluations in the protocol, or likely to confound the efficacy or safety observations of the study (e.g., concurrent malignancies, history of unstable angina, repeated myocardial infarction or congestive heart failure, renal insufficiency, uncontrolled asthma or diabetes, unstable thyroid disease or other significant hormonal conditions, uncontrolled seizure disorders, severe psychiatric disorders, active tuberculosis under current treatment, etc
研究者
相似试验
进行中（未招募）
1 期
A randomized, open label pilot study to investigate the effect of chronic administration of buprenorphine prior to arthroplasty on the opioid requirements of patients intraoperatively and postoperatively. - Date: Final 26 April 2004EUCTR2005-003009-10-GBBarts and The London NHS Trust75
尚未招募
Unknown
Controlling womens body weight by dietary management physical exercises and lifestyle modificatioCTRI/2024/06/068576Thirumalai Charity Trust
尚未招募
不适用
Effect of Psychological Intervention in Patients with Irritable Bowel SyndromeCTRI/2022/10/046801AIIMS New Delhi
终止
2 期
Aerosolized surfactant in the first hour of lifeInfant Respiratory Distress SyndromeRespiratory - Other respiratory disorders / diseasesReproductive Health and Childbirth - Childbirth and postnatal careReproductive Health and Childbirth - Complications of newbornACTRN12610000857000School of Women’s and Infants’ Health (SWIH)110
进行中（未招募）
不适用
An open label, randomized pilot study to evaluate diagnostic treatment interruption in HIV-positive children under a stable antiretroviral therapy in order to save medication and reduce possible side effects.B24Unspecified human immunodeficiency virus [HIV] diseaseDRKS00000473J.W. Goethe UniversitätZentrum für Kinder- und Jugendmedizin1